Menicon Co., Ltd. (TYO:7780)

Market Cap	133.66B +60.5%
Revenue (ttm)	127.73B +5.1%
Net Income	7.16B +47.6%
EPS	95.72 +57.4%
Shares Out	74.26M
PE Ratio	18.81
Forward PE	18.53
Dividend	28.00 (1.56%)
Ex-Dividend Date	Mar 30, 2026

Volume	196,200
Open	1,802.00
Previous Close	1,792.00
Day's Range	1,798.00 - 1,841.00
52-Week Range	1,118.00 - 2,086.00
Beta	0.65
Analysts	Buy
Price Target	2,250.00 (+25.0%)
Earnings Date	Nov 13, 2026

About Menicon

Menicon Co., Ltd. produces and sells contact lenses in Japan and internationally. It operates through Vision Care Business and Others segments. The company offers disposable lenses, MTO specialty lenses, myopia management products, and lens care products. It also engages in the manufacture and sale of medical instruments; sale of medical supplies; research and development of intraocular lenses; healthcare business comprising products utilizing self-assembling peptide gel technology and bone graft substitute materials; life care business consist...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1943
• Employees: 4,493
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 7780

Financial Performance

In fiscal year 2026, Menicon's revenue was 125.61 billion, an increase of 3.39% compared to the previous year's 121.49 billion. Earnings were 5.92 billion, an increase of 5.25%.

Analyst Summary

According to 4 analysts, the average rating for 7780 stock is "Buy." The 12-month stock price target is ¥2,250, which is an increase of 25.00% from the latest price.

Price Target

¥2,250

(25.00% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 6, 2026

Data Sources Report a data error